+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gallium-68"

Italy Radiopharmaceuticals Market By Radioisotope, By Application, By Type, By End User: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Italy Radiopharmaceuticals Market By Radioisotope, By Application, By Type, By End User: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 74 Pages
  • Italy
From
Prostate Cancer, An Issue of PET Clinics. The Clinics: Internal Medicine Volume 17-4 - Product Thumbnail Image

Prostate Cancer, An Issue of PET Clinics. The Clinics: Internal Medicine Volume 17-4

  • Book
  • October 2022
Loading Indicator

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases. Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more